Shorter lyme treatment may be just as effective: 7-day doxycycline trial
NCT ID NCT03337932
First seen May 07, 2026 · Last updated May 24, 2026 · Updated 4 times
Summary
This study tests whether a 7-day course of doxycycline works as well as the standard 14-day course for people with multiple Lyme disease rashes (multiple erythema migrans). About 200 participants will be randomly assigned to one of the two treatment lengths. Researchers will track symptoms and any return of Lyme signs for up to a year to see if the shorter treatment is enough.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ERYTHEMA CHRONICUM MIGRANS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Medical center Ljubljana
RECRUITINGLjubljana, Slovenia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.